NASDAQ:DXCM - Nasdaq - US2521311074 - Common Stock - Currency: USD
Overall DXCM gets a fundamental rating of 6 out of 10. We evaluated DXCM against 187 industry peers in the Health Care Equipment & Supplies industry. While DXCM has a great profitability rating, there are some minor concerns on its financial health. DXCM is not overvalued while it is showing excellent growth. This is an interesting combination. This makes DXCM very considerable for growth investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.93% | ||
ROE | 23.61% | ||
ROIC | 14.54% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 16.54% | ||
PM (TTM) | 12.9% | ||
GM | 60.72% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.57 | ||
Debt/FCF | 4.35 | ||
Altman-Z | 5.92 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.5 | ||
Quick Ratio | 1.32 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 50.26 | ||
Fwd PE | 32.03 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 56.53 | ||
EV/EBITDA | 33.49 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
82.93
-0.65 (-0.78%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 50.26 | ||
Fwd PE | 32.03 | ||
P/S | 7.84 | ||
P/FCF | 56.53 | ||
P/OCF | 33.73 | ||
P/B | 14.35 | ||
P/tB | 15.14 | ||
EV/EBITDA | 33.49 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.93% | ||
ROE | 23.61% | ||
ROCE | 18.47% | ||
ROIC | 14.54% | ||
ROICexc | 53.32% | ||
ROICexgc | 60.37% | ||
OM | 16.54% | ||
PM (TTM) | 12.9% | ||
GM | 60.72% | ||
FCFM | 13.87% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.57 | ||
Debt/FCF | 4.35 | ||
Debt/EBITDA | 1.42 | ||
Cap/Depr | 172.69% | ||
Cap/Sales | 9.38% | ||
Interest Coverage | 250 | ||
Cash Conversion | 105.79% | ||
Profit Quality | 107.47% | ||
Current Ratio | 1.5 | ||
Quick Ratio | 1.32 | ||
Altman-Z | 5.92 |